http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103040829-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f9c84be899083b74df4e19624981a78
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf8d2fb693b29d0502d4e0e124be4c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aba9194f414db32a315b91aa1ee2d37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18906c4ce1bcff1a1c6b528b9c4fd161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_195a0cb6caf8adddaacdc104341a917c
publicationDate 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103040829-B
titleOfInvention Pharmaceutical composition containing lappaconitine and oxycodone
abstract The invention relates to a pharmaceutical composition containing lappaconitine and oxycodone for treating pain. The pharmaceutical composition contains a treatment effective quantity of lappaconitine or a pharmaceutically acceptable salt thereof or a solvate thereof, a treatment effective quantity of oxycodone or a pharmaceutically acceptable salt thereof and an optional pharmaceutically acceptable carrier. The invention further relates to a use of the composition containing the treatment effective quantity of lappaconitine or the pharmaceutically acceptable salt thereof or the solvate thereof and the treatment effective quantity of oxycodone or the pharmaceutically acceptable salt thereof in the preparation of medicines for relieving pain. The pharmaceutical composition and the use, disclosed by the invention, have the beneficial effects as described in the specification.
priorityDate 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451008255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448124138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406961784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5355255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51346120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449212221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423279168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452482248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22326455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68767429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44558878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493286

Total number of triples: 46.